Pfizer loses appeal against $10.4M Prempro verdict; Xalkori wins European recommendation;

@FiercePharma: Indian companies often plant moles to spy on competitors and hire hackers to dig into IT systems, survey finds. More | Follow @FiercePharma

> Pfizer ($PFE) has to pay the $10.4 million in damages awarded to a woman who blamed the hormone treatment Prempro for her breast cancer, an appeals court said. Report

> European regulators gave a thumbs up to condition approval of Pfizer's targeted lung cancer treatment Xalkori. Report

> Boehringer Ingelheim CEO Andreas Barner lamented the financial crisis and its effect on his company, saying the U.S. looks "difficult" as well. Report

> Novartis' ($NVS) generics unit Sandoz wrapped up its $1.5 billion acquisition of the specialty dermatology company Fougera Pharmaceuticals, formerly the U.S unit of Swiss-based Nycomed. Report

> For the first time, an international expert panel has recommended that all patients who test positive for HIV should be treated with antiretroviral drug. Report

> India's Aurobindo Pharma won FDA approval for its version of the diabetes drug metformin. Report

Biotech News

 @FierceBiotech: Can Merck's suvorexant wake up the lethargic market for new sleep drugs? More | Follow @FierceBiotech

 @JohnCFierce: PTC investors back lead orphan drug with $30M round. Story | Follow @JohnCFierce

 @RyanMFierce: Venter and Stanford built first complete software model of organism, a simple bacterium. Simulated humans someday? More | Follow @RyanMFierce

> Biotech execs get creative as venture cash flow dwindles. More

> Cell Medica lands $26.5M in venture cash to fuel U.S. expansion. News

> PTC investors back lead orphan drug with $30M round. Article

Medical Device News

@FierceMedDev: Philips Healthcare grows solidly during Q2. More | Follow @FierceMedDev

 @MarkHFierce: In a novel twist for NIH funding, a $65M grant is designed to boost translational device/Dx research. Item | Follow @MarkHFierce

 @DamianFierce: Navidea is moving forward in the Alzheimer's imaging race, vying with GE Healthcare and Eli Lilly. Story | Follow @DamianFierce

> Navidea moves forward in race for next-gen Alzheimer's imaging. More

> IntelligentMDx wins CE mark for new herpes test. News

> $65M NIH grant propels U.W. translational research institute. Article

> Fresenius grabs blood collection device maker Fenwal Holdings. Story

CRO News

> DSM expands CMO biz with first Brazilian deal. Story

> Indian PM urged to tax CMOs in excise-free zones. Article

> Parexel partners to develop drugs in S. Korea. News

> CoreRx triples capacity with Florida plant. Item

> Covance selling off animal testing lab. Article

Biotech IT News

> 10 Reasons Why Biotech Needs Big Data. Special Report

> Pfizer builds credentials as 'data company'. More

> Medidata CEO seeks organic growth over big eClinical buyouts. Item

> WorldOne takes over Sermo social network for docs. News

> NCI spotlights cancer gene-drug matchmaker software. Story

And Finally... As the Olympic torch wends its way through the U.S., GlaxoSmithKline's ($GSK) drug-testing lab for athletes is ready for action. Report